AMED News and Press, Amedisys Inc From 04/03/23

2023-04-03 20:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-25 05:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BATON ROUGE, La., March 23, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care, supports the findings from the NORC at the University of Chicago study released by the National Association for Home Care & Hospice (NAHC) and ...

2023-03-15 13:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-13 17:38:29 ET Amedisys ( NASDAQ: AMED ) on Monday said it had named Richard Ashworth as its president and CEO. Ashworth will assume the role from current CEO Paul Kusserow on April 10, AMED said in a statement . Kusserow will remain chairman of A...

BATON ROUGE, La., March 13, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), the leading provider of quality home health, hospice, and high-acuity care services, today announced that its Board of Directors has named Richard Ashworth as President, Chief Executive Officer, and member of the ...

Amedisys and nVoq Present Outcomes from Speech Recognition Study at PALTC23 Conference PR Newswire BOULDER, Colo. , March 9, 2023 /PRNewswire/ -- nVoq Incorporated, the in-home healthcare industry's leading provider of HIPAA compliant speech recognition solutions...

2023-03-05 21:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Summary Amedisys delivered a mixed set of Q4 numbers, with upsides vs consensus. In more detail, growth was inconsistent across key divisions and further down the P&L. Returns on capital below the hurdle rate remain as a key tension point. Looks overpriced at 26x earnings. R...

Amedisys, Inc. (AMED) Q4 2022 Earnings Conference Call February 16, 2023, 11:00 ET Company Participants Nick Muscato - Chief Strategy Officer Paul Kusserow - Chairman & CEO Scott Ginn - EVP, CFO & Acting COO Adam Holton - Chief People Officer Conferen...